68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

NCT ID: NCT02358018


Title
68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial
Purpose
The purpose of this study is to use a new type of scan, called 68Ga-DOTATOC PET/CT scan, instead of OctreoScan, the standard scan, to diagnose, monitor and manage your tumor. 68Ga-DOTATOC is an improved imaging agent being routinely used in many centers outside the USA, with better tumor detection than with OctreoScan.
Details
Conditions
Neuroendocrine Tumors
Keywords
68Ga-DOTATOC, PET/CT scan, 14-226
Source
Memorial Sloan Kettering Cancer Center
Sponsors
Memorial Sloan Kettering Cancer Center
Status
No longer available
Acronym
Last Updated
31 Oct 2016
URL
Official Link
Locations
United States